Immediate Impact

1 by Nobel laureates 11 from Science/Nature 87 standout
Sub-graph 1 of 11

Citing Papers

IL-10 constrains sphingolipid metabolism to limit inflammation
2024 StandoutNature
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
2023 Standout
1 intermediate paper

Works of Christopher H. Cabell being referenced

Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
2021
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
2019

Author Peers

Author Last Decade Papers Cites
Christopher H. Cabell 3922 2706 2126 66 5.8k
Jean‐Paul Casalta 5473 2594 2274 85 6.8k
Paola Anna Erba 3938 1436 1834 144 6.8k
Adnan S. Dajani 2732 1660 957 91 5.7k
G. Ralph Corey 2800 3558 999 85 6.4k
Richard E. Nettles 3847 3174 900 39 5.8k
Franck Thuny 6007 2724 4416 145 9.8k
Vivian H. Chu 2696 2167 1060 77 4.0k
José M. Miró 5150 3036 2019 84 6.1k
José M. Miró 3766 3232 986 223 5.9k
M. Rizwan Sohail 3063 1683 2893 215 5.9k

All Works

Loading papers...

Rankless by CCL
2026